Immunovaccine Inc., a clinical stage immunotherapy and vaccine company, is expanding its collaboration with Leidos to develop preventative malaria vaccine candidates.   The U.S. Agency for International Development (USAID) supported the collaboration from the start, providing a sub-contract to Leido’s malaria vaccine development program. After that collaboration resulted in several preclinical milestones, Leidos and USAID have now chosen the DepoVax-based platform for further development...